Article
[Characteristics of PIK3CA gene mutations in Her2-low breast cancer].
Arkhiv patologii - 1 Jan 2023
Pavlenko I A, Povilaitite P E, Makarevich N S, Kaciyaev V Yu, Petrov A V
Abstract excerpt
BACKGROUND: Mutations in the PIK3CA gene, encoding the catalytic subunit of the PI3K class IA p110α, is a common mechanism of activating of PI3K/AKT/mTOR pathway in breast cancer (BC). The detection of these mutations in patients with hormone-positive Her2-negative BC is of important clinical value, since they are the predictor of the sensitivity of the tumor to the PI3K inhibitor - alpelisib. According to the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
